Live Breaking News & Updates on Alliqua Inc

Stay updated with breaking news from Alliqua inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ZYVERSA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 5, 2023, the Board of Directors. | January 6, 2023 ....

New Jersey , United States , United Kingdom , Macalester College , Bio Pharma , Katrin Rupalla , Gregory Freitag , Stephen Glover , James Sapirstein , Ambrx Biopharma Inc , Compensation Committee , Lectec Corporation , Biotechnology Corporation , Research Development Quality At Lundbeck , Axogen Inc , Pfizer Inc , Head Oncology Global Regulatory Sciences , Companies Section Governing Board , University Of Chicago , Contravir Pharmaceuticals , Corporate Governance Committee , Guidant Corporation , Sd Pharma , Zyversa Therapeutics Inc , Exchange Commission , Cancer Drug Development Fund ,

ZyVersa Therapeutics Appoints Three New Board Members

/PRNewswire/ ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or "ZyVersa"), a clinical- stage specialty biopharmaceutical company developing first-in-class drugs. ....

Robertg Finizio , Katrin Rupalla , Gregoryg Freitag , Ambrx Biopharma , Stephenc Glover , Daniel Oconnor , James Sapirstein , Enochian Biosciences , Lectec Corporation , Axogen Inc , Pfizer Inc , Companies Section Governing Board , Contravir Pharmaceuticals , Gilead Sciences , Prnewswire Zyversa Therapeutics Inc , Guidant Corporation , Zyversa Therapeutics Inc , Pfizer Health Solutions , Cancer Drug Development Forum , Alliqua Inc , Securities Exchange , Quantech Ltd , Business Development , Versa Therapeutics , Executive Director , Danielo Connor ,

ZyVersa Therapeutics Appoints Three New Board Members

New appointments bring expertise and proven leadership to ZyVersa to support advancement and development of VAR 200 for renal disease, and IC 100 . ....

Robertg Finizio , Katrin Rupalla , Gregoryg Freitag , Ambrx Biopharma , Stephenc Glover , Daniel Oconnor , James Sapirstein , Enochian Biosciences , Lectec Corporation , Axogen Inc , Pfizer Inc , Companies Section Governing Board , Contravir Pharmaceuticals , Prnewsfoto Variant Pharmaceuticals Inc , Gilead Sciences , Prnewswire Zyversa Therapeutics Inc , Guidant Corporation , Zyversa Therapeutics Inc , Pfizer Health Solutions , Cancer Drug Development Forum , Alliqua Inc , Securities Exchange , Quantech Ltd , Business Development , Versa Therapeutics , Variant Pharmaceuticals ,

In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews James Sapirstein CEO, First Wave BioPharma, Inc.

NEW YORK, NY / ACCESSWIRE / October 6, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued ....

United States , Fairleigh Dickinson University , New Jersey , Rutgers University , Boca Raton , Dave Schemelia , Toni Loudenbeck , Mark Roberts , Eli Lilly , Enochian Biosciences , James Sapirstein , Tiberend Strategic Advisors Inc , Gilead Sciences Inc , Biotechnology Innovation Organization , First Wave Biopharma Inc , Alliqua Inc , International Marketing , Traders News Source , Companies Section Governing Board , Bristol Myers Squibb , Contravir Pharmaceuticals , First Wave , Chief Executive Officer , First Wave Biopharma , News Source , Infectious Diseases ,